Cohort study | Epidemiology and outcomes of hospital-acquired bloodstream infections in ICU patients

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study – Intensive Care Medicine (if the link is paywalled, try this one)

Commentary on Twitter

Hospital‑acquired bloodstream infections in #ICU, @EuroBact2
🧫mainly due to Gram -, widespread carbapenem resistant, DTR pathogens
🧫resistance associated w longer delays to adequate ABT therapy
At day-28
🧫mortality 37%
🧫16.1% discharged alive from 🏥
🖇️https://t.co/0T4FK2mxc5 pic.twitter.com/e0u50hMKqO

— Intensive Care Medicine (@yourICM) February 11, 2023